allosteric BACE inhibition by deformable nanovesicle or protein nanocapsules delivered sAPPalpha (Univ California)

N/A

Report date: 2025/01/26 17:55:28
NME

Base Information

Drug Nameallosteric BACE inhibition by deformable nanovesicle or protein nanocapsules delivered sAPPalpha (Univ California)
Drug Alias NameDNV-hsAPPalphan(hsAPPalpha)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California, Los Angeles
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A